15
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: found
      Is Open Access

      Integrating cellular senescence with the concept of damage accumulation in aging: Relevance for clearance of senescent cells

      review-article

      Read this article at

      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Understanding the aging process and ways to manipulate it is of major importance for biology and medicine. Among the many aging theories advanced over the years, the concept most consistent with experimental evidence posits the buildup of numerous forms of molecular damage as a foundation of the aging process. Here, we discuss that this concept integrates well with recent findings on cellular senescence, offering a novel view on the role of senescence in aging and age‐related disease. Cellular senescence has a well‐established role in cellular aging, but its impact on the rate of organismal aging is less defined. One of the most prominent features of cellular senescence is its association with macromolecular damage. The relationship between cell senescence and damage concerns both damage as a molecular signal of senescence induction and accelerated accumulation of damage in senescent cells. We describe the origin, regulatory mechanisms, and relevance of various damage forms in senescent cells. This view on senescent cells as carriers and inducers of damage puts new light on senescence, considering it as a significant contributor to the rise in organismal damage. Applying these ideas, we critically examine current evidence for a role of cellular senescence in aging and age‐related diseases. We also discuss the differential impact of longevity interventions on senescence burden and other types of age‐related damage. Finally, we propose a model on the role of aging‐related damage accumulation and the rate of aging observed upon senescent cell clearance.

          Related collections

          Most cited references152

          • Record: found
          • Abstract: found
          • Article: not found

          Cellular senescence in aging and age-related disease: from mechanisms to therapy.

          Cellular senescence, a process that imposes permanent proliferative arrest on cells in response to various stressors, has emerged as a potentially important contributor to aging and age-related disease, and it is an attractive target for therapeutic exploitation. A wealth of information about senescence in cultured cells has been acquired over the past half century; however, senescence in living organisms is poorly understood, largely because of technical limitations relating to the identification and characterization of senescent cells in tissues and organs. Furthermore, newly recognized beneficial signaling functions of senescence suggest that indiscriminately targeting senescent cells or modulating their secretome for anti-aging therapy may have negative consequences. Here we discuss current progress and challenges in understanding the stressors that induce senescence in vivo, the cell types that are prone to senesce, and the autocrine and paracrine properties of senescent cells in the contexts of aging and age-related diseases as well as disease therapy.
            Bookmark
            • Record: found
            • Abstract: found
            • Article: found
            Is Open Access

            The Achilles’ heel of senescent cells: from transcriptome to senolytic drugs

            The healthspan of mice is enhanced by killing senescent cells using a transgenic suicide gene. Achieving the same using small molecules would have a tremendous impact on quality of life and the burden of age-related chronic diseases. Here, we describe the rationale for identification and validation of a new class of drugs termed senolytics, which selectively kill senescent cells. By transcript analysis, we discovered increased expression of pro-survival networks in senescent cells, consistent with their established resistance to apoptosis. Using siRNA to silence expression of key nodes of this network, including ephrins (EFNB1 or 3), PI3Kδ, p21, BCL-xL, or plasminogen-activated inhibitor-2, killed senescent cells, but not proliferating or quiescent, differentiated cells. Drugs targeting these same factors selectively killed senescent cells. Dasatinib eliminated senescent human fat cell progenitors, while quercetin was more effective against senescent human endothelial cells and mouse BM-MSCs. The combination of dasatinib and quercetin was effective in eliminating senescent MEFs. In vivo, this combination reduced senescent cell burden in chronologically aged, radiation-exposed, and progeroid Ercc1 −/Δ mice. In old mice, cardiac function and carotid vascular reactivity were improved 5 days after a single dose. Following irradiation of one limb in mice, a single dose led to improved exercise capacity for at least 7 months following drug treatment. Periodic drug administration extended healthspan in Ercc1 −/Δ mice, delaying age-related symptoms and pathology, osteoporosis, and loss of intervertebral disk proteoglycans. These results demonstrate the feasibility of selectively ablating senescent cells and the efficacy of senolytics for alleviating symptoms of frailty and extending healthspan.
              Bookmark
              • Record: found
              • Abstract: found
              • Article: not found

              Oxidative stress shortens telomeres.

              Telomeres in most human cells shorten with each round of DNA replication, because they lack the enzyme telomerase. This is not, however, the only determinant of the rate of loss of telomeric DNA. Oxidative damage is repaired less well in telomeric DNA than elsewhere in the chromosome, and oxidative stress accelerates telomere loss, whereas antioxidants decelerate it. I suggest here that oxidative stress is an important modulator of telomere loss and that telomere-driven replicative senescence is primarily a stress response. This might have evolved to block the growth of cells that have been exposed to a high risk of mutation.
                Bookmark

                Author and article information

                Contributors
                m.ogrodnik@newcastle.ac.uk
                vgladyshev@rics.bwh.harvard.edu
                Journal
                Aging Cell
                Aging Cell
                10.1111/(ISSN)1474-9726
                ACEL
                Aging Cell
                John Wiley and Sons Inc. (Hoboken )
                1474-9718
                1474-9726
                22 October 2018
                February 2019
                : 18
                : 1 ( doiID: 10.1111/acel.2019.18.issue-1 )
                : e12841
                Affiliations
                [ 1 ] Institute for Cell and Molecular Biosciences Newcastle University Institute for Ageing Newcastle upon Tyne UK
                [ 2 ] Division of Genetics Department of Medicine Brigham and Women's Hospital and Harvard Medical School Boston Massachusetts
                Author notes
                [*] [* ] Correspondence

                Mikolaj Ogrodnik, Institute for Cell and Molecular Biosciences, Newcastle University Institute for Ageing, Newcastle upon Tyne, UK.

                Email: m.ogrodnik@ 123456newcastle.ac.uk

                and

                Vadim N. Gladyshev, Division of Genetics, Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, MA.

                Email: vgladyshev@ 123456rics.bwh.harvard.edu

                Author information
                http://orcid.org/0000-0003-3137-2037
                http://orcid.org/0000-0002-9444-1039
                http://orcid.org/0000-0002-0372-7016
                Article
                ACEL12841
                10.1111/acel.12841
                6351832
                30346102
                98c076df-6caf-4345-816c-80c38778f875
                © 2018 The Authors. Aging Cell published by the Anatomical Society and John Wiley & Sons Ltd.

                This is an open access article under the terms of the http://creativecommons.org/licenses/by/4.0/ License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.

                History
                : 20 May 2018
                : 31 July 2018
                : 20 August 2018
                Page count
                Figures: 5, Tables: 0, Pages: 21, Words: 18891
                Funding
                Funded by: BBSRC
                Funded by: MRC
                Funded by: NIH
                Categories
                Review
                Reviews
                Custom metadata
                2.0
                acel12841
                February 2019
                Converter:WILEY_ML3GV2_TO_NLMPMC version:5.5.7 mode:remove_FC converted:30.01.2019

                Cell biology
                aging,cellular senescence,deleteriome,evolutionary biology,lifespan,molecular damage,theories of aging

                Comments

                Comment on this article